A non-invasive breast cancer screening test, Revealia Breast offers glimpse to future of early cancer detection

Join Pharma | Login

	Editorial


	THE FORCED SWIM TEST
	Tuesday, May 6, 2025
	The animal rights organization, People for the Ethical Treatment of Animals (PETA) has recently sent a letter to the Pharmacy Council of India (PCI) for discontinuing the Forced Swim Test (FST) in thousands of pharmacy institutions across the country.
	Past Editorial...

TODAY'S NEWS


11:00 [IST]	A non-invasive breast cancer screening test, Revealia Breast offers glimpse to future of early cancer detection
10:00 [IST]	GSK’s GLISTEN phase III trial of linerixibat in adults with cholestatic pruritus and PBC meets the primary endpoint
09:00 [IST]	Merck Animal Health and State of Kansas announce $895 million investment in manufacturing and R&D facilities in De Soto, Kansas

more news >>

TOP NEWS


08:00 [IST]	CDSCO revises guidelines for issuance of export NOC for unapproved, approved new drugs
08:00 [IST]	Gujarat FDCA cracks down on illegal sale of narcotic and psychotropic drugs
08:00 [IST]	Indian lifesciences sector faces recruiting challenges in on-boarding job-ready talent: Dr Purav Gandhi
08:00 [IST]	DTAB backs ICMR recommendations on use of nimesulide in adults, suggests further review
08:00 [IST]	Radiologists seek to offset fatigue & burnout with tech adoption across imaging centres to avert diagnostic errors
08:00 [IST]	Revised guidelines on biosimilars elaborates conditions for waiver of animal studies

more news >>

YESTERDAY'S NEWS


17:25 [IST]	Lupin receives US FDA approval for raltegravir tablets USP, 600 mg
17:15 [IST]	FABA, IIL & ABF launch Finishing School Programme in Hyderabad giving a boost to lifesciences career
16:45 [IST]	Agilent inaugurates India Solution Centre to accelerate innovation and expand the frontiers of science
16:30 [IST]	Sun Pharma launches corporate brand campaign in India
16:15 [IST]	Nanavati Max Hospital introduces most advanced orthopaedics, spine & joint care centres
15:45 [IST]	Johnson & Johnson Medtech partners with Qure.ai to boost early detection of lung cancer in India

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

Poly Medicure net profit grows 34 per cent in Q4FY25 Alembic Pharma reports 12% decline in net profit during Q4FY25 OneSource reports Rs. 426 crore revenues with 22% growth in Q4 & 30% rise at Rs. 1,444.9 crore in FY25 Syngene’s revenue from operations crossed Rs. 1,000 crore mark in Q4, PAT dips by 3%, full year earnings up 4% to Rs. 3,642 crore Methotrexate 2.5 Mg Tab/cap

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers